Aurora Cannabis Sets February 4 Call to Discuss Q3 2026 Results
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aurora Cannabis ( (TSE:ACB) ) has shared an announcement.
On January 21, 2026, Aurora Cannabis announced it will release its financial results for the third quarter of fiscal 2026 before markets open and host an investor conference call and webcast later that morning, on Wednesday, February 4, 2026, led by Executive Chairman and CEO Miguel Martin and CFO Simona King. The scheduled call underscores the company’s effort to maintain active communication with investors as it advances its position as a leading global medical and consumer cannabis player, offering stakeholders a forthcoming update on operating performance and strategic progress during a period of ongoing competition and regulatory complexity in the cannabis sector.
The most recent analyst rating on (TSE:ACB) stock is a Hold with a C$6.50 price target. To see the full list of analyst forecasts on Aurora Cannabis stock, see the TSE:ACB Stock Forecast page.
Spark’s Take on TSE:ACB Stock
According to Spark, TipRanks’ AI Analyst, TSE:ACB is a Neutral.
Aurora Cannabis faces significant financial challenges, with ongoing losses and cash flow issues weighing heavily on its score. While recent earnings call highlights and strategic investments in international markets provide some optimism, the overall outlook remains cautious due to valuation concerns and technical indicators suggesting bearish momentum.
To see Spark’s full report on TSE:ACB stock, click here.
More about Aurora Cannabis
Aurora Cannabis Inc. is a Canadian-based, global medical and consumer cannabis company headquartered in Edmonton, Alberta, with operations and sales across Canada, Europe, Australia and South America. The company markets a portfolio of adult-use brands including Drift, San Rafael ’71, Daily Special, Tasty’s, Being and Greybeard, and medical brands such as MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., along with international medical brands Pedanios, IndiMed and CraftPlant. Aurora also holds a controlling interest in Bevo Farms Ltd., a major North American supplier of propagated agricultural plants, and its shares trade on the NASDAQ and TSX under the symbol ACB.
Average Trading Volume: 559,198
Technical Sentiment Signal: Sell
Current Market Cap: C$330M
For a thorough assessment of ACB stock, go to TipRanks’ Stock Analysis page.
